Results 171 to 180 of about 45,688 (235)

Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma. [PDF]

Clin Cancer Res
Pant S, Park JO, Su WC, Loriot Y, Carranza O, Corassa M, Doi T, Qin S, Tabernero J, Prenen H, Folprecht G, Winter H, Dal Molin GZ, Shen L, Qian J, Liao H, Thomas S, Sweiti H, Triantos S, Feng YH.   +19 more
europepmc   +1 more source

The m6Am methyltransferase PCIF1 promotes osteogenic differentiation of mesenchymal stem cells through stabilization of Wnt-related transcripts. [PDF]

PLoS Biol
Song W, Su KJ, Pan Z, Zhang Z, Yin Q, Lin W, Liu L, Gong Y, Liang B, Cai Y, Li Q, Shen H, Deng HW, Yuan Q.   +13 more
europepmc   +1 more source

PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models. [PDF]

Clin Cancer Res
Juric D, Song K, Johnson RM, Accordino MK, Bedard PL, Cervantes A, Gambardella V, Hamilton E, Italiano A, Kalinsky K, Krop IE, Oliveira M, Saura C, Schmid P, Turner NC, Varga A, Gendreau S, Hwang MS, Kuang Z, Lau JT, Lin E, Pham T, Maddalo D, Rees MG, Ronan MM, Roth JA, Martin S, Sodir NM, Sokol ES, Whitfield ZJ, Wong A, Yauch RL, Aimi J, Cheeti S, Fredrickson J, Hilz S, Hafner M, Hutchinson KE, Jin Y, Peters U, Zingg D, Royer-Joo S, Shankar N, Schutzman JL, Jhaveri KL, Dey A.   +45 more
europepmc   +1 more source

FGFR2 Gene Mutation Negative [PDF]

, 2020
openaire   +1 more source

Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301. [PDF]

ESMO Open
Abou-Alfa GK, Borbath I, Roychowdhury S, Goyal L, Lamarca A, Macarulla T, Shroff RT, Oh DY, Tamaş C, Savastano DM, van Veenhuyzen DF, Xu C, Freas E, Solanas J, Javle MM.   +14 more
europepmc   +1 more source

FGFR2 Gene Rearrangement Negative [PDF]

, 2020
openaire   +1 more source

Correction to "Sprouty2 Suppresses Progression and Correlates to Favourable Prognosis of Intrahepatic Cholangiocarcinoma via Antagonizing FGFR2 Signalling". [PDF]

J Cell Mol Med
europepmc   +1 more source

DyVarMap: Integrating Conformational Dynamics and Interpretable Machine Learning for Cancer-Associated Missense Variant Classification in FGFR2. [PDF]

Bioengineering (Basel)
Lian Y, Shehu A.
europepmc   +1 more source

Anti-FGFR2 Antibody BAY1179470 [PDF]

, 2020
openaire   +1 more source

Uralenol, Glycyrol, and Abyssinone II as potent inhibitors of fibroblast growth factor receptor 2 from anti-cancer plants: A deep learning and molecular dynamics approach. [PDF]

PLoS One
Hossain A, Hossan MS, Prodhan MS, Joy MNH, Siam MR, Rahman ME, Matin MN.   +6 more
europepmc   +1 more source